92 related articles for article (PubMed ID: 30563883)
1. HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.
Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
Blood Adv; 2018 Dec; 2(24):3590-3601. PubMed ID: 30563883
[TBL] [Abstract][Full Text] [Related]
2. Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation.
Crivello P; Arrieta-Bolaños E; He M; Wang T; Fingerson S; Gadalla SM; Paczesny S; Marsh SGE; Lee SJ; Spellman SR; Bolon YT; Fleischhauer K
J Clin Oncol; 2023 May; 41(13):2416-2427. PubMed ID: 36669145
[TBL] [Abstract][Full Text] [Related]
3. Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant.
Solomon SR; Aubrey MT; Bachier-Rodriguez L; Solh MM; Jackson KC; Zhang X; Roark CL; Holland HK; Morris LE; Bashey A
Transplant Cell Ther; 2024 Mar; ():. PubMed ID: 38561140
[TBL] [Abstract][Full Text] [Related]
4. HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis.
Fukunaga K; Ikegame K; Nakamae H; Doki N; Fukuda T; Kondo Y; Ara T; Eto T; Mori Y; Matsuoka KI; Kanda Y; Onizuka M; Atsuta Y; Ichinohe T; Morishima S; Kanda J;
Int J Hematol; 2024 Feb; 119(2):173-182. PubMed ID: 38233701
[TBL] [Abstract][Full Text] [Related]
5. Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-leukemia Effects via HLA-B Leader in HLA-haploidentical Peripheral Blood Stem Cell Transplantation.
Moriguchi M; Ido K; Okamura H; Nakamae M; Sakatoku K; Makuuchi Y; Kuno M; Takakuwa T; Hirose A; Nishimoto M; Nakashima Y; Koh H; Hino M; Nakamae H
Acta Haematol; 2024 Mar; ():. PubMed ID: 38432202
[TBL] [Abstract][Full Text] [Related]
6. Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
Hamdi A; Cao K; Poon LM; Aung F; Kornblau S; Fernandez Vina MA; Champlin RE; Ciurea SO
Bone Marrow Transplant; 2015 Mar; 50(3):411-3. PubMed ID: 25621795
[TBL] [Abstract][Full Text] [Related]
7. The rise of haplo: a quest for the perfect graft.
Weinacht KG
Blood; 2024 Jan; 143(3):193-195. PubMed ID: 38236615
[No Abstract] [Full Text] [Related]
8. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
Biol Blood Marrow Transplant; 2020 Jan; 26(1):123-131. PubMed ID: 31563575
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Cryopreservation on Hematopoietic Stem Cell Engraftment and Post-transplant Outcome During the COVID-19 Pandemic.
Strzelec A; Gawlik-Rzemieniewska N; Klima A; Panek K; Helbig G
In Vivo; 2024; 38(3):1271-1277. PubMed ID: 38688614
[TBL] [Abstract][Full Text] [Related]
10. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation.
Iwasaki M; Kanda J; Tanaka H; Shindo T; Sato T; Doki N; Fukuda T; Ozawa Y; Eto T; Uchida N; Katayama Y; Kataoka K; Ara T; Ota S; Onizuka M; Kanda Y; Ichinohe T; Atsuta Y; Morishima S
Front Immunol; 2022; 13():811733. PubMed ID: 35309307
[TBL] [Abstract][Full Text] [Related]
11. HLA-EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities.
Geffard E; Boussamet L; Walencik A; Delbos F; Limou S; Gourraud PA; Vince N
HLA; 2022 Feb; 99(2):79-92. PubMed ID: 34862850
[TBL] [Abstract][Full Text] [Related]
12. Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation.
Kobayashi S; Sano H; Mochizuki K; Ohara Y; Takahashi N; Kudo S; Ikeda K; Ohto H; Kikuta A
Int J Hematol; 2022 Mar; 115(3):414-423. PubMed ID: 34822127
[TBL] [Abstract][Full Text] [Related]
13. Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
Zou J; Wang T; He M; Bolon YT; Gadalla SM; Marsh SGE; Kuxhausen M; Gale RP; Sharma A; Assal A; Prestidge T; Aljurf M; Cerny J; Paczesny S; Spellman SR; Lee SJ; Ciurea SO
Transplant Cell Ther; 2022 Feb; 28(2):107.e1-107.e8. PubMed ID: 34774819
[TBL] [Abstract][Full Text] [Related]
14. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
[TBL] [Abstract][Full Text] [Related]
15. Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.
Zou J; Ciurea SO; Kongtim P; Yi M; Carmazzi Y; Rondon G; Srour S; Partlow D; Champlin RE; Cao K
Blood Adv; 2020 Aug; 4(15):3474-3485. PubMed ID: 32726398
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.
Ikegame K; Kaida K; Fukunaga K; Osugi Y; Yoshihara K; Yoshihara S; Ishii S; Fujino S; Yamashita T; Mayumi A; Maruyama S; Teramoto M; Inoue T; Okada M; Tamaki H; Ogawa H; Fujimori Y
Bone Marrow Transplant; 2021 Jan; 56(1):70-83. PubMed ID: 32564055
[TBL] [Abstract][Full Text] [Related]
17. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.
McCurdy SR; Luznik L
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):513-521. PubMed ID: 31808908
[TBL] [Abstract][Full Text] [Related]
18. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.
McCurdy SR; Luznik L
Blood; 2019 Nov; 134(21):1802-1810. PubMed ID: 31751485
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
